{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:10:06Z","timestamp":1785402606863,"version":"3.56.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Struct Funct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) and diabetes mellitus (DM) share common pathophysiological features. However, the effects of antidiabetic drugs on neurodegeneration are not completely known. Canagliflozin, a novel option for DM treatment, is a dual inhibitor of sodium glucose co-transporter type 2 (SGLT2) and acetylcholinesterase. The aim of this study is to examine the morphological features of dendrites and dendritic spines of pyramidal neurons in hippocampus of AD model treated with canagliflozin. The model of AD was obtained by intracerebroventricular injection of streptozotocin. Then, the rats were divided into 3 groups: vehicle, donepezil, and canagliflozin. The injections were i.c.v. administered for 7 days. Behavioral tests were performed to evaluate memory, anxiety, and motor functions. Brain tissues were processed by Golgi impregnation method. Pyramidal neurons in the CA1 region were examined using Neurolucida software. Dendritic branching, total dendrite length, dendritic spine density, and dendritic spine types were analyzed. Compared to the vehicle group, the donepezil group and the canagliflozin group exhibited significantly higher dendritic branches (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0273,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0195) and total dendrite length (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0171,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0360), respectively. The total dendritic spine density (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) and the mushroom-type dendritic spine density (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001) were significantly low in the donepezil group compared to the vehicle group. However, canagliflozin did not induce any significant alterations in the dendritic spine density. Canagliflozin treatment was as effective as donepezil treatment on hippocampal dendrite morphology. This morphological framework, indicating dendritic plasticity and remodeling, serve to better understand the cellular effects of canagliflozin. Therefore, our study may contribute to the development of novel strategies for therapy of AD.\n                  <\/jats:p>","DOI":"10.1007\/s00429-026-03142-4","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:58:52Z","timestamp":1781456332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer\u2019s disease induced by intracerebroventricular injection of streptozotocin"],"prefix":"10.1007","volume":"231","author":[{"given":"Sevdenur","family":"Yazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Buldu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Karakose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan","family":"Cakmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selenay","family":"Somunkiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan R.","family":"Yananli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit S.","family":"Sehirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Kirazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"issue":"4","key":"3142_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/er.2010-0029","volume":"32","author":"MA Abdul-Ghani","year":"2011","unstructured":"Abdul-Ghani MA, Norton L, DeFronzo RA (2011) Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes. Endocr Rev 32(4):515\u2013531. https:\/\/doi.org\/10.1210\/er.2010-0029","journal-title":"Endocr Rev"},{"key":"3142_CR2","doi-asserted-by":"publisher","unstructured":"Apaijai N, Attachaipanich T, Maneechote C et al (2025) Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction. Biochimica et Biophysica Acta (BBA) Mol Basis Dis 1871(5):167809. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167809","DOI":"10.1016\/j.bbadis.2025.167809"},{"key":"3142_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cbi.2017.08.013","volume":"277","author":"NM Arafa","year":"2017","unstructured":"Arafa NM, Ali EH, Hassan MK (2017) Canagliflozin prevents scopolamine-induced memory impairment in rats: comparison with galantamine hydrobromide action. Chemico Biol Interact 277:195\u2013203. https:\/\/doi.org\/10.1016\/j.cbi.2017.08.013","journal-title":"Chemico-Biol Interact"},{"issue":"2","key":"3142_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tips.2010.11.011","volume":"32","author":"CJ Bailey","year":"2011","unstructured":"Bailey CJ (2011) Renal glucose reabsorption inhibitors to treat diabetes. Trends Pharmacol Sci 32(2):63\u201371. https:\/\/doi.org\/10.1016\/j.tips.2010.11.011","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"3142_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/ijms24021059","volume":"24","author":"B-K Beata","year":"2023","unstructured":"Beata B-K, Wojciech J, Johannes K, Piotr L, Barbara M (2023) Alzheimer\u2019s disease\u2014biochemical and psychological background for diagnosis and treatment. Int J Mol Sci 24(2):1059. https:\/\/doi.org\/10.3390\/ijms24021059","journal-title":"Int J Mol Sci"},{"key":"3142_CR6","doi-asserted-by":"publisher","unstructured":"Belyaev G, Petrov K, Semenov V, Zueva I (2025) Changes in dendritic spine density and morphology during therapy with acetylcholinesterase inhibitors in a mouse model of Alzheimer\u2019s disease. Bull Exp Biol Med. https:\/\/doi.org\/10.1007\/s10517-025-06493-w","DOI":"10.1007\/s10517-025-06493-w"},{"issue":"24","key":"3142_CR7","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25(24):5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"issue":"3\u20134","key":"3142_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cm.21583","volume":"77","author":"M Bucher","year":"2020","unstructured":"Bucher M, Fanutza T, Mikhaylova M (2020) Cytoskeletal makeup of the synapse: shaft versus spine. Cytoskeleton 77(3\u20134):55\u201364. https:\/\/doi.org\/10.1002\/cm.21583","journal-title":"Cytoskeleton"},{"key":"3142_CR9","doi-asserted-by":"publisher","unstructured":"Burgos IG, Nikonenko I, Korz V (2012) Dendritic spine plasticity and cognition. Neural Plast 2012. https:\/\/doi.org\/10.1155\/2012\/875156","DOI":"10.1155\/2012\/875156"},{"key":"3142_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainresbull.2013.12.004","volume":"103","author":"JN Cochran","year":"2014","unstructured":"Cochran JN, Hall AM, Roberson ED (2014) The dendritic hypothesis for Alzheimer\u2019s disease pathophysiology. Brain Res Bull 103:18\u201328. https:\/\/doi.org\/10.1016\/j.brainresbull.2013.12.004","journal-title":"Brain Res Bull"},{"issue":"5","key":"3142_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/alzrt215","volume":"5","author":"D Cutuli","year":"2013","unstructured":"Cutuli D, De Bartolo P, Caporali P et al (2013) Neuroprotective effects of donepezil against cholinergic depletion. Alzheimers Res Ther 5(5):50. https:\/\/doi.org\/10.1186\/alzrt215","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3142_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11011-024-01478-6","volume":"40","author":"AS Davri","year":"2024","unstructured":"Davri AS, Katsenos AP, Tulyaganova GK et al (2024) The SGLT2 inhibitor empagliflozin exerts neuroprotective effect against hydrogen peroxide-induced toxicity on primary neurons. Metab Brain Dis 40(1):15. https:\/\/doi.org\/10.1007\/s11011-024-01478-6","journal-title":"Metab Brain Dis"},{"issue":"1","key":"3142_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/JAD-2009-1035","volume":"17","author":"P De Bartolo","year":"2009","unstructured":"De Bartolo P, Gelfo F, Mandolesi L, Foti F, Cutuli D, Petrosini L (2009) Effects of chronic donepezil treatment and cholinergic deafferentation on parietal pyramidal neuron morphology. J Alzheimer\u2019s Dis 17(1):177\u2013191. https:\/\/doi.org\/10.3233\/JAD-2009-1035","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"6","key":"3142_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1523\/JNEUROSCI.2723-07.2008","volume":"28","author":"DF de Sevilla","year":"2008","unstructured":"de Sevilla DF, N\u00fanez A, Borde M, Malinow R, Buno W (2008) Cholinergic-mediated IP3-receptor activation induces long-lasting synaptic enhancement in CA1 pyramidal neurons. J Neurosci 28(6):1469\u20131478. https:\/\/doi.org\/10.1523\/JNEUROSCI.2723-07.2008","journal-title":"J Neurosci"},{"issue":"1","key":"3142_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","volume":"23","author":"B Dejanovic","year":"2024","unstructured":"Dejanovic B, Sheng M, Hanson JE (2024) Targeting synapse function and loss for treatment of neurodegenerative diseases. Nat Rev Drug Discov 23(1):23\u201342. https:\/\/doi.org\/10.1038\/s41573-023-00823-1","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"3142_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00213-013-3152-3","volume":"230","author":"A Easton","year":"2013","unstructured":"Easton A, Sankaranarayanan S, Tanghe A et al (2013) Effects of sub-chronic donepezil on brain abeta and cognition in a mouse model of Alzheimer\u2019s disease. Psychopharmacology 230(2):279\u2013289. https:\/\/doi.org\/10.1007\/s00213-013-3152-3","journal-title":"Psychopharmacology"},{"key":"3142_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fncel.2014.00022","volume":"8","author":"NB El Khoury","year":"2014","unstructured":"El Khoury NB, Gratuze M, Papon M-A, Bretteville A, Planel E (2014) Insulin dysfunction and tau pathology. Front Cell Neurosci 8:22. https:\/\/doi.org\/10.3389\/fncel.2014.00022","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"3142_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/medicina60111805","volume":"60","author":"HA Elariny","year":"2024","unstructured":"Elariny HA, Kabel AM, Selim HMRM et al (2024) Repositioning canagliflozin for mitigation of aluminium chloride-induced Alzheimer\u2019s disease: involvement of TXNIP\/NLRP3 inflammasome axis, mitochondrial dysfunction, and SIRT1\/HMGB1 signalling. Medicina 60(11):1805. https:\/\/doi.org\/10.3390\/medicina60111805","journal-title":"Medicina"},{"key":"3142_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.neuroscience.2015.01.058","volume":"290","author":"H Guo","year":"2015","unstructured":"Guo H, Cheng Y, Wu J et al (2015) Donepezil improves learning and memory deficits in APP\/PS1 mice by inhibition of microglial activation. Neuroscience 290:530\u2013542. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.01.058","journal-title":"Neuroscience"},{"issue":"12","key":"3142_CR20","doi-asserted-by":"publisher","first-page":"8916","DOI":"10.1007\/s12035-018-0985-0","volume":"55","author":"S Gupta","year":"2018","unstructured":"Gupta S, Yadav K, Mantri SS, Singhal NK, Ganesh S, Sandhir R (2018) Evidence for compromised insulin signaling and neuronal vulnerability in experimental model of sporadic Alzheimer\u2019s disease. Mol Neurobiol 55(12):8916\u20138935. https:\/\/doi.org\/10.1007\/s12035-018-0985-0","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3142_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-020-00607-4","volume":"12","author":"C Hierro-Bujalance","year":"2020","unstructured":"Hierro-Bujalance C, Infante-Garcia C, Del Marco A et al (2020) Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer\u2019s disease and type 2 diabetes. Alzheimers Res Ther 12(1):40. https:\/\/doi.org\/10.1186\/s13195-020-00607-4","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"3142_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.201003008","volume":"189","author":"P Hotulainen","year":"2010","unstructured":"Hotulainen P, Hoogenraad CC (2010) Actin in dendritic spines: connecting dynamics to function. J Cell Biol 189(4):619\u2013629. https:\/\/doi.org\/10.1083\/jcb.201003008","journal-title":"J Cell Biol"},{"issue":"6","key":"3142_CR23","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s10787-022-00973-5","volume":"30","author":"WW Ibrahim","year":"2022","unstructured":"Ibrahim WW, Kamel AS, Wahid A, Abdelkader NF (2022) Dapagliflozin as an autophagic enhancer via LKB1\/AMPK\/SIRT1 pathway in ovariectomized\/D-galactose Alzheimer\u2019s rat model. Inflammopharmacology 30(6):2505\u20132520. https:\/\/doi.org\/10.1007\/s10787-022-00973-5","journal-title":"Inflammopharmacology"},{"key":"3142_CR24","doi-asserted-by":"publisher","unstructured":"Jayarathne H, Manchanayake DH, Sullivan R et al (2025) Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET 3 mice and attenuates Alzheimer\u2019s\u2010like pathology. Aging Cell. https:\/\/doi.org\/10.1111\/acel.70255","DOI":"10.1111\/acel.70255"},{"issue":"5","key":"3142_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41401-019-0334-5","volume":"41","author":"W-x Jian","year":"2020","unstructured":"Jian W-x, Zhang Z, Zhan J-h et al (2020) Donepezil attenuates vascular dementia in rats through increasing BDNF induced by reducing HDAC6 nuclear translocation. Acta Pharmacol Sin 41(5):588\u2013598. https:\/\/doi.org\/10.1038\/s41401-019-0334-5","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"3142_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0166-2236(03)00162-0","volume":"26","author":"H Kasai","year":"2003","unstructured":"Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H (2003) Structure\u2013stability\u2013function relationships of dendritic spines. Trends Neurosci 26(7):360\u2013368. https:\/\/doi.org\/10.1016\/S0166-2236(03)00162-0","journal-title":"Trends Neurosci"},{"issue":"1","key":"3142_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/13543784.2022.2022122","volume":"31","author":"AP Katsenos","year":"2022","unstructured":"Katsenos AP, Davri AS, Simos YV et al (2022) New treatment approaches for Alzheimer\u2019s disease: preclinical studies and clinical trials centered on antidiabetic drugs. Expert Opin Investig Drugs 31(1):105\u2013123. https:\/\/doi.org\/10.1080\/13543784.2022.2022122","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"3142_CR28","doi-asserted-by":"publisher","first-page":"e7917","DOI":"10.1371\/journal.pone.0007917","volume":"4","author":"YD Ke","year":"2009","unstructured":"Ke YD, Delerue F, Gladbach A, G\u00f6tz J, Ittner LM (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer\u2019s disease. PLoS ONE 4(11):e7917. https:\/\/doi.org\/10.1371\/journal.pone.0007917","journal-title":"PLoS ONE"},{"issue":"1","key":"3142_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11481-024-10140-y","volume":"19","author":"SM Khamies","year":"2024","unstructured":"Khamies SM, El-Yamany MF, Ibrahim SM (2024) Canagliflozin mitigated cognitive impairment in streptozotocin-induced sporadic Alzheimer\u2019s disease in mice: role of AMPK\/SIRT-1 signaling pathway in modulating neuroinflammation. J Neuroimmune Pharmacol 19(1):39. https:\/\/doi.org\/10.1007\/s11481-024-10140-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"3142_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuro.2013.10.004","volume":"40","author":"HG Kim","year":"2014","unstructured":"Kim HG, Moon M, Choi JG et al (2014) Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo. Neurotoxicology 40:23\u201332. https:\/\/doi.org\/10.1016\/j.neuro.2013.10.004","journal-title":"Neurotoxicology"},{"issue":"19","key":"3142_CR31","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.3390\/ijms221910637","volume":"22","author":"J Kim","year":"2021","unstructured":"Kim J, Lee H-j, Park SK et al (2021) Donepezil regulates LPS and A\u03b2-stimulated neuroinflammation through MAPK\/NLRP3 inflammasome\/STAT3 signaling. Int J Mol Sci 22(19):10637. https:\/\/doi.org\/10.3390\/ijms221910637","journal-title":"Int J Mol Sci"},{"key":"3142_CR32","doi-asserted-by":"publisher","unstructured":"Kostrzewska P, Kuca P, Witek P, Ma\u0142yszko J, Madetko Alster N, Alster P (2025) SGLT-2 inhibitors in the prevention and progression of neurodegenerative diseases: a narrative review. Neurol Therapy 1\u201318. https:\/\/doi.org\/10.1007\/s40120-025-00832-9","DOI":"10.1007\/s40120-025-00832-9"},{"issue":"5","key":"3142_CR33","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/j.1471-4159.2010.06852.x","volume":"114","author":"TY Kuo","year":"2010","unstructured":"Kuo TY, Chen CY, Hsueh YP (2010) Bcl11A\/CTIP1 mediates the effect of the glutamate receptor on axon branching and dendrite outgrowth. J Neurochem 114(5):1381\u20131392. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06852.x","journal-title":"J Neurochem"},{"issue":"1","key":"3142_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ydbio.2018.12.005","volume":"451","author":"V Lanoue","year":"2019","unstructured":"Lanoue V, Cooper HM (2019) Branching mechanisms shaping dendrite architecture. Dev Biol 451(1):16\u201324. https:\/\/doi.org\/10.1016\/j.ydbio.2018.12.005","journal-title":"Dev Biol"},{"issue":"1","key":"3142_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.neuro.27.070203.144157","volume":"27","author":"JL McGaugh","year":"2004","unstructured":"McGaugh JL (2004) The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27(1):1\u201328. https:\/\/doi.org\/10.1146\/annurev.neuro.27.070203.144157","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"3142_CR36","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/acer.13599","volume":"42","author":"PJ Mulholland","year":"2018","unstructured":"Mulholland PJ, Teppen TL, Miller KM, Sexton HG, Pandey SC, Swartzwelder HS (2018) Donepezil reverses dendritic spine morphology adaptations and Fmr1 epigenetic modifications in hippocampus of adult rats after adolescent alcohol exposure. Alcohol Clin Exp Res 42(4):706\u2013717. https:\/\/doi.org\/10.1111\/acer.13599","journal-title":"Alcoholism: Clin Experimental Res"},{"issue":"1\u20133","key":"3142_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2012.12.023","volume":"703","author":"A Nagakura","year":"2013","unstructured":"Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N (2013) Characterization of cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease and effects of donepezil and memantine. Eur J Pharmacol 703(1\u20133):53\u201361. https:\/\/doi.org\/10.1016\/j.ejphar.2012.12.023","journal-title":"Eur J Pharmacol"},{"key":"3142_CR38","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D, Edison P (2023) Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 89:101979. https:\/\/doi.org\/10.1016\/j.arr.2023.101979","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3142_CR39","doi-asserted-by":"publisher","first-page":"165975","DOI":"10.1016\/j.bbadis.2020.165975","volume":"1867","author":"B Ongnok","year":"2021","unstructured":"Ongnok B, Khuanjing T, Chunchai T et al (2021) Donepezil provides neuroprotective effects against brain injury and Alzheimer\u2019s pathology under conditions of cardiac ischemia\/reperfusion injury. Biochim et Biophys Acta (BBA) Mol Basis Dis 1867(1):165975. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165975","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Basis Disease"},{"key":"3142_CR40","unstructured":"Ovalle WK, Nahirney PC (2020) Netter\u2019s essential histology: Netter\u2019s essential histology E-book. Elsevier Health Sciences"},{"issue":"23","key":"3142_CR41","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3390\/molecules26237213","volume":"26","author":"A Pawlos","year":"2021","unstructured":"Pawlos A, Broncel M, Wo\u017aniak E, Gorzelak-Pabi\u015b P (2021) Neuroprotective effect of SGLT2 inhibitors. Molecules 26(23):7213. https:\/\/doi.org\/10.3390\/molecules26237213","journal-title":"Molecules"},{"key":"3142_CR42","unstructured":"Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates: hard cover edition. Elsevier"},{"key":"3142_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnsyn.2020.00031","volume":"12","author":"E Pchitskaya","year":"2020","unstructured":"Pchitskaya E, Bezprozvanny I (2020) Dendritic spines shape analysis\u2014classification or clusterization? Perspective. Front Synaptic Neurosci 12:31. https:\/\/doi.org\/10.3389\/fnsyn.2020.00031","journal-title":"Front Synaptic Neurosci"},{"issue":"3","key":"3142_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nn.2741","volume":"14","author":"P Penzes","year":"2011","unstructured":"Penzes P, Cahill ME, Jones KA, VanLeeuwen J-E, Woolfrey KM (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14(3):285\u2013293. https:\/\/doi.org\/10.1038\/nn.2741","journal-title":"Nat Neurosci"},{"issue":"2","key":"3142_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/156720509787602861","volume":"6","author":"G Pepeu","year":"2009","unstructured":"Pepeu G, Giovannini MG (2009) Cholinesterase inhibitors and beyond. Curr Alzheimer Res 6(2):86\u201396. https:\/\/doi.org\/10.2174\/156720509787602861","journal-title":"Curr Alzheimer Res"},{"key":"3142_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","volume":"333","author":"P Sa-Nguanmoo","year":"2017","unstructured":"Sa-Nguanmoo P, Tanajak P, Kerdphoo S et al (2017) SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicol Appl Pharmcol 333:43\u201350. https:\/\/doi.org\/10.1016\/j.taap.2017.08.005","journal-title":"Toxicol Appl Pharmcol"},{"key":"3142_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-211-73574-9_28","volume":"72","author":"M Salkovic-Petrisic","year":"2007","unstructured":"Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 72:217. https:\/\/doi.org\/10.1007\/978-3-211-73574-9_28","journal-title":"J neural transmission Suppl"},{"issue":"1","key":"3142_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1476-5381.2010.00894.x","volume":"161","author":"H Shen","year":"2010","unstructured":"Shen H, Kihara T, Hongo H et al (2010) Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of \u03b17 nicotinic receptors and internalization of NMDA receptors. Br J Pharmacol 161(1):127\u2013139. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00894.x","journal-title":"Br J Pharmacol"},{"issue":"11","key":"3142_CR49","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/ph16111620","volume":"16","author":"GD Stanciu","year":"2023","unstructured":"Stanciu GD, Ababei DC, Solcan C et al (2023) Preclinical studies of canagliflozin, a sodium-glucose co-transporter 2 inhibitor, and donepezil combined therapy in Alzheimer\u2019s disease. Pharmaceuticals 16(11):1620. https:\/\/doi.org\/10.3390\/ph16111620","journal-title":"Pharmaceuticals"},{"issue":"1","key":"3142_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1073858418769644","volume":"25","author":"IS Stein","year":"2019","unstructured":"Stein IS, Zito K (2019) Dendritic spine elimination: molecular mechanisms and implications. Neuroscientist 25(1):27\u201347. https:\/\/doi.org\/10.1177\/1073858418769644","journal-title":"Neuroscientist"},{"issue":"40","key":"3142_CR51","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1523\/JNEUROSCI.1664-20.2020","volume":"40","author":"HJ Stratton","year":"2020","unstructured":"Stratton HJ, Khanna R (2020) Sculpting dendritic spines during initiation and maintenance of neuropathic pain. J Neurosci 40(40):7578\u20137589. https:\/\/doi.org\/10.1523\/JNEUROSCI.1664-20.2020","journal-title":"J Neurosci"},{"issue":"1","key":"3142_CR52","doi-asserted-by":"publisher","first-page":"4981814","DOI":"10.1155\/2020\/4981814","volume":"2020","author":"Y Sun","year":"2020","unstructured":"Sun Y, Ma C, Sun H et al (2020) Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease. J Diabetes Res 2020(1):4981814. https:\/\/doi.org\/10.1155\/2020\/4981814","journal-title":"J Diabetes Res"},{"issue":"2","key":"3142_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2(2):322\u2013328. https:\/\/doi.org\/10.1038\/nprot.2007.44","journal-title":"Nat Protoc"},{"key":"3142_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2014.06.046","volume":"287","author":"Y Wu","year":"2015","unstructured":"Wu Y, Liu D, Song Z (2015) Neuronal networks and energy bursts in epilepsy. Neuroscience 287:175\u2013186. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.06.046","journal-title":"Neuroscience"},{"issue":"7","key":"3142_CR54","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1249\/MSS.0000000000002294","volume":"52","author":"C Wu","year":"2020","unstructured":"Wu C, Yang L, Li Y et al (2020) Effects of exercise training on anxious\u2013depressive-like behavior in Alzheimer rat. Med Sci Sports Exerc 52(7):1456. https:\/\/doi.org\/10.1249\/MSS.0000000000002294","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"3142_CR57","doi-asserted-by":"publisher","first-page":"e108645","DOI":"10.1371\/journal.pone.0108645","volume":"9","author":"Z-P Xu","year":"2014","unstructured":"Xu Z-P, Li L, Bao J et al (2014) Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer\u2019s model. PLoS ONE 9(9):e108645. https:\/\/doi.org\/10.1371\/journal.pone.0108645","journal-title":"PLoS ONE"},{"issue":"2","key":"3142_CR56","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11064-017-2426-2","volume":"43","author":"Z-P Xu","year":"2018","unstructured":"Xu Z-P, Gan G-S, Liu Y-M et al (2018) Adiponectin attenuates streptozotocin-induced tau hyperphosphorylation and cognitive deficits by rescuing PI3K\/Akt\/GSK-3\u03b2 pathway. Neurochem Res 43(2):316\u2013323. https:\/\/doi.org\/10.1007\/s11064-017-2426-2","journal-title":"Neurochem Res"},{"issue":"1","key":"3142_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00429-024-02868-3","volume":"230","author":"S Yazi","year":"2024","unstructured":"Yazi S, Sehirli US, Gulhan R, Onat F, Kirazli O (2024) Evaluation of dendrite morphology in Wistar and genetic absence epileptic rats. Brain Struct Funct 230(1):5. https:\/\/doi.org\/10.1007\/s00429-024-02868-3","journal-title":"Brain Struct Function"},{"key":"3142_CR59","unstructured":"Yuste R (2023) Dendritic spines. MIT Press"},{"issue":"4","key":"3142_CR60","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-2012-120151","volume":"31","author":"R Zhang","year":"2012","unstructured":"Zhang R, Xue G, Wang S, Zhang L, Shi C, Xie X (2012) Novel object recognition as a facile behavior test for evaluating drug effects in A\u03b2PP\/PS1 Alzheimer\u2019s disease mouse model. J Alzheimer\u2019s Dis 31(4):801\u2013812. https:\/\/doi.org\/10.3233\/JAD-2012-120151","journal-title":"J Alzheimer\u2019s Disease"},{"key":"3142_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang N-q, Yan F et al (2018) Diabetes mellitus and Alzheimer\u2019s disease: GSK-3\u03b2 as a potential link. Behav Brain Res 339:57\u201365. https:\/\/doi.org\/10.1016\/j.bbr.2017.11.015","journal-title":"Behav Brain Res"}],"container-title":["Brain Structure and Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00429-026-03142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00429-026-03142-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00429-026-03142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:01:50Z","timestamp":1785398510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00429-026-03142-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3142"],"URL":"https:\/\/doi.org\/10.1007\/s00429-026-03142-4","relation":{},"ISSN":["1863-2661"],"issn-type":[{"value":"1863-2661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol is approved by the Marmara University Local Ethics Committee for Animal Experiments (Protocol Code: 54.2022mar).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"87"}}